Board of Directors

Galenica’s Board of Directors consists of six members and has ultimate responsibility for the company and its subsidiaries’ business and affairs. The Board of Directors is composed of highly experienced experts and personalities with decades of industry experience and extensive knowledge about the Galenica business.

Dr. Jörg Kneubühler
Chairman of the Board of Directors

  • Elected since 2017
  • Born 1960, Swiss citizen
  • Dr. rer. pol., University of Bern
  • Held various positions in finance at the Swatch Group before joining Galenica
  • Joined the former Galenica Group in 2002 as Head of Finance and Administration at Vifor Pharma; Head of Controlling for the Galenica Group as of 2006; Head Corporate Finance and Controlling for the Galenica Group and member of the Corporate Executive Committee since 2009; CFO from 2012 to 2016; Head Human Resources from 2012 until 2014; and from 2014 until 2017 CEO Galenica Santé

Daniela Bosshardt-Hengartner

  • Elected since 2017
  • Born 1972, Swiss citizen
  • Pharmacist, Federal Diploma in Pharmacy, Federal Institute of Technology, Zurich
  • Financial analyst at Bank am Bellevue (1998-2002) and M2 Capital (2003-2004)
  • Management consultant in the pharmaceutical, medical technology and biotechnology sectors since 2004
  • Member of the Board of Directors of RepRisk AG (Zurich), Vifor Pharma Ltd. (Zürich) and (Baar)

Prof. Dr. Michel Burnier

  • Elected since 2017
  • Born 1953, Swiss citizen
  • Swiss-registered Doctor of Internal Medicine and Nephrology
  • University Lecturer, University of Lausanne
  • Member of the following organisations: Swiss Society of Nephrology (former President), European Society of Hypertension (council member and Treasurer) and Swiss Society of Hypertension (former President)
  • Formerly a member of the Medicines Committee of the Swiss Association of Pharmacists (until 2001), the Board of Swissmedic (2002-2010)
  • Member of the Board of Directors of Speedel Holding Ltd. (Basel) from 2007 to 2009
  • Member of the Board of Directors of Vifor Pharma Ltd. (Zurich)

Fritz Hirsbrunner

  • Elected since 2017
  • Born 1949, Swiss citizen
  • Lic. oec., HEC University of Lausanne/Senior Executive Program, IMD, Lausanne
  • 1972–1977 Controller at Ciba-Geigy
  • Joined the former Galenica Group in 1977 as Assistant to the Corporate Executive Committee; member of the Corporate Executive Committee and CFO from 1992 to 2011; from 2009 Deputy CEO; Head Investor Relations until 2014
  • Member of the Board of Trustees of IST Investmentstiftung für Personalvorsorge (Zurich)
  • Member of the Board of Directors of Berlac AG (Sissach), IVF Hartmann Holding AG (Neuhausen), VenCap 6 Ltd. (Jersey) and Vifor Pharma Ltd. (Zurich)

Dr. Philippe Nussbaumer

  • Elected since 2017
  • Born in 1969, Swiss citizen
  • FPH Pharmacist, Fed. Diploma / PhD in Pharm. Sciences, University of Geneva / dipl. oec. HEC, University of Lausanne
  • Director of the Pharmacie Centrale and the Pharmacie de la Gare in La Chaux-de-Fonds and of Veripharm SA
  • Since 2007, founder and director of the ECOPHARMA pharmacy brand; since 2014, founder and director of the Medi-Centre SA medical centre in La Chaux-de-Fonds
  • Since 2004, Vice-President of Swiss Ski School Neuchâtel-Les Bugnenets

Dr. Andreas Walde

  • Elected since 2017
  • Born 1962, Swiss citizen
  • Attorney-at-law and doctorate in law, University of Basel
  • Various legal and management positions in the chemical and pharmaceutical industry for more than 25 years: 1988-1996 at Roche, 1998-2010 at Clariant and 2012-2013 at Petroplus, in the latter two notably as group general counsel; General Secretary of Vifor Pharma Ltd. (Zurich), former Galenica Group, since 2013
  • Former positions include memberships on the boards of several private (non-Swiss) public listed companies as well as on the board of the Society of Swiss Enterprises in Germany
  • Member of the Board of SwissHoldings, the Federation of Industrial and Service Groups in Switzerland